Real-world effectiveness of rotavirus vaccines, 2006–19: a literature review and meta-analysis

E Burnett, UD Parashar, JE Tate - The Lancet Global Health, 2020 - thelancet.com
Background Since licensure in 2006, rotavirus vaccines have been introduced in more than
100 countries. The efficacy of rotavirus vaccines is variable in settings with different child …

Mumps

A Hviid, S Rubin, K Mühlemann - The Lancet, 2008 - thelancet.com
Mumps is a common childhood infection caused by the mumps virus. The hallmark of
infection is swelling of the parotid gland. Aseptic meningitis and encephalitis are common …

Effectiveness of one dose of MVA–BN smallpox vaccine against mpox in England using the case-coverage method: an observational study

M Bertran, N Andrews, C Davison… - The Lancet Infectious …, 2023 - thelancet.com
Background The UK experienced a national outbreak of mpox (formerly known as
monkeypox) disease that started in May, 2022, as did many other countries worldwide, with …

[HTML][HTML] Effectiveness of COVID-19 vaccines in preventing hospitalization among adults aged≥ 65 years—COVID-NET, 13 states, February–April 2021

HL Moline - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65
Years — COVID-NET, 13 States, February–April 2021 | MMWR Skip directly to site content …

Effectiveness of maternal pertussis vaccination in England: an observational study

G Amirthalingam, N Andrews, H Campbell, S Ribeiro… - The Lancet, 2014 - thelancet.com
Summary Background In October, 2012, a pertussis vaccination programme for pregnant
women was introduced in response to an outbreak across England. We aimed to assess the …

Vaccination of infants with meningococcal group B vaccine (4CMenB) in England

SN Ladhani, N Andrews, SR Parikh… - … England Journal of …, 2020 - Mass Medical Soc
Abstract Background In September 2015, the United Kingdom introduced the
multicomponent meningococcal group B vaccine (4CMenB, Bexsero) into its publicly funded …

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

SR Parikh, NJ Andrews, K Beebeejaun, H Campbell… - The Lancet, 2016 - thelancet.com
Summary Background In September, 2015, the UK became the first country to introduce the
multicomponent group B meningococcal (MenB) vaccine (4CMenB, Bexsero) into a publicly …

Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction

G Amirthalingam, H Campbell, S Ribeiro… - Clinical Infectious …, 2016 - academic.oup.com
The effectiveness of maternal immunization in preventing infant pertussis was first
demonstrated in England, 1 year after the program using diphtheria–tetanus–5-component …

Effectiveness of vaccination during pregnancy to prevent infant pertussis

R Baxter, J Bartlett, B Fireman, E Lewis, NP Klein - Pediatrics, 2017 - publications.aap.org
BACKGROUND: Vaccination against pertussis during pregnancy is recommended to protect
newborns, yet there is limited information about the effectiveness of maternal tetanus toxoid …

[HTML][HTML] Early COVID-19 vaccine effectiveness of XBB. 1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December …

CH van Werkhoven, AW Valk, B Smagge… - …, 2024 - eurosurveillance.org
We present early vaccine effectiveness (VE) estimates of the 2023 seasonal COVID-19 XBB.
1.5 vaccine against COVID-19 hospitalisation and admission to an intensive care unit (ICU) …